MNTA

Momenta Pharmaceuticals Stock Price

52.48
0.00 (0.0%)
52.48
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Momenta Pharmaceuticals Inc MNTA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 52.48 19:00:00
Open Price Low Price High Price Close Price Previous Close
52.48
Bid Price Ask Price Spread News
47.70 52.45 4.75 - -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 52.48 USD

Momenta Pharmaceuticals Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 6.24B 118.97M 115.09M $ 23.87M $ - -2.93 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Momenta Pharmaceuticals News

Date Time Source News Article
11/10/202010:28Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)
10/13/202008:15Edgar (US Regulatory)Termination of Registration of a Class of Security Under..
10/01/202017:19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
10/01/202017:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
10/01/202017:14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
10/01/202017:11Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
10/01/202017:09Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical MNTA Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.0%
1 Month0.000.000.000.0000.000.0%
3 Months52.1752.5352.0052.273,479,1740.310.59%
6 Months34.9854.0026.8646.672,706,22317.5050.03%
1 Year15.5754.0015.2538.921,821,00436.91237.06%
3 Years13.7554.009.5129.09980,25938.73281.67%
5 Years17.8654.007.8624.45832,13434.62193.84%

Momenta Pharmaceuticals Description

Momenta is a biotechnology company focused on the characterization and development of innovative drugs in autoimmune diseases. Its legacy business includes complex generic versions of MS drug Copaxone and anticoagulant Lovenox, and it receives royalties for these products through a partnership with Novartis. While a biosimilar version of Eylea is in the pipeline, Momenta terminated future development in generics/biosimilars in 2018. Several innovative drugs, including nipocalimab, M254, and M230, are in development to treat rare autoimmune diseases.
Your Recent History
NASDAQ
MNTA
Momenta Ph..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20201125 13:35:42